An Observational Study of Lumosity in Seniors
1 other identifier
observational
68
1 country
1
Brief Summary
The primary objective of this observational study is to determine performance characteristics and usability of Lumosity and the Brain Performance Test in a group of older adult volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 18, 2015
CompletedFirst Posted
Study publicly available on registry
November 25, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2017
CompletedMay 25, 2017
May 1, 2017
1.6 years
November 18, 2015
May 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Usability - as measured by self-report feedback surveys
Using self-report surveys administered to participants at baseline, 3 months and 6 months, investigators will calculate a usability score of Lumosity.
Change from Baseline - collected at baseline, 3 months and 6 months
Secondary Outcomes (3)
User Engagement - as measured by number of unique days played
6 months
Change from baseline on the Lumosity Performance Index (LPI)
Change from Baseline - collected at baseline and 6 months
Change from baseline on the Brain Performance Test (BPT)
Change from Baseline - collected at baseline, 3 months and 6 months
Eligibility Criteria
Participants must be cognitively stable older adult volunteers(over 55 years of age)
You may qualify if:
- Participants must meet the following criteria:
- years of age or older
- English-speaker
- Cognitively stable (i.e., without a known diagnosis that may affect cognitive abilities)
- Regular access to and ability to use a computer or mobile device with Internet connectivity.
You may not qualify if:
- Under 55 years of age
- Have a current diagnosed cognitive or neuropsychological condition
- Are taking medication that may impede cognitive functioning
- Anticipate a dosage change in medication that may affect cognitive functioning during the course of the study (24 weeks)
- Have other conditions or problems that may preclude regular computer usage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lumos Labs, Inc.lead
Study Sites (1)
Lumos Labs, Inc.
San Francisco, California, 94105, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Glenn Morrison, PhD
Lumos Labs
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2015
First Posted
November 25, 2015
Study Start
November 1, 2015
Primary Completion
May 23, 2017
Study Completion
May 23, 2017
Last Updated
May 25, 2017
Record last verified: 2017-05